FDA Closes Loophole Drugmakers Use to Avoid Pediatric Studies

December 27, 2017

The Food and Drug Administration (FDA) is closing a loophole that drugmakers have used to avoid performing pediatric studies (82 Fed. Reg. 60,402).

Related Stories